Cellectar reports full exercise of Tranche A warrants raising $44.1M

Cellectar Biosciences, Inc.

Tranche A warrants from September 2023 financing exercised in full.
Gross proceeds of approximately $44.1 million from the warrant exercise.
No other details on use of proceeds provided in the filing.

item 8.01

Cellectar Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-006709

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.